Friday, June 19, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 914 of 1,261

  1. US 8227494

    Pharmaceutical compositions of 1,2,4-oxadiazole benzoic acid and their use for the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted

  2. US 8226977

    Pharmaceutical composition containing irbesartan

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted

  3. US 8227473

    Oxabicycloheptanes and oxabicycloheptenes, their preparation and use

    Lixte Biotechnology, Inc. · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted

  4. US 8227455

    Methods of treating cell proliferative disorders

    Rigel Pharmaceuticals, Inc. · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted

  5. US 8227443

    Silencing of CSN5 gene expression using interfering RNA

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted

  6. US 8227446

    Oligodeoxynucleotide and its use to induce an immune response

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted

  7. US 8227615

    Pyridyl derivatives as CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted

  8. US 8227438

    Suppressors of CpG oligonucleotides and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted

  9. US 8222215

    Methods for the use of inhibitors of antigen presentation by MHC class II molecules

    Provid Pharmaceuticals Inc. · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  10. US 8222015

    Heat resistant bioactive composition

    Regents of the University of Minnesota · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  11. US 8222288

    Small molecule inhibitors of MDM2 and the uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  12. US 8222411

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  13. US 8221737

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  14. US 8221772

    Pulmonary surfactant formulations and methods for promoting mucus clearance

    Discovery Laboratories, Inc. · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  15. US 8221768

    Chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  16. US 8221764

    Secreted campylobacter flagella coregulated proteins as immunogens

    United States of America as represented by the Secretary of the Air Force · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  17. US 8221138

    Audio jack connector with improved soldering tail

    Hon Hai Precision Ind. Co., Ltd. · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  18. US 8222203

    Macrocyclic oximyl hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  19. US 8221804

    Compositions and methods for enhancing cognitive function

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  20. US 8221763

    Yeast-antigen compositions and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  21. US 8222222

    Compositions and methods for inhibiting expression of the PCSK9 gene

    Alnylam Pharmaceuticals, Inc. · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  22. US 8222218

    Cyclopropanated carbohydrates

    Seton Hall University · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  23. US 8222225

    Method of treating pneumoconiosis with oligodeoxynucleotides

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  24. US 8222242

    Nitric oxide releasing compounds

    The Regents of the University of California · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.